CB
About
Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection. The company pursues the research, development, and commercialization of proprietary products that have the potential to treat cancer, prevent, and treat acute radiation syndrome and counteract the toxic effects of radio and chemotherapies for oncology patients. Cleveland BioLabs was established in 2003 and is headquartered in Buffalo, New York.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Buffalo, US
Contact Information
Find more investors like Cleveland
Search Investors